These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4204546)

  • 1. The plasminogen activator of vampire bat saliva.
    Cartwright T
    Blood; 1974 Mar; 43(3):317-26. PubMed ID: 4204546
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitor of platelet aggregation present in saliva of the vampire bat Desmodus rotundus.
    Hawkey C
    Br J Haematol; 1967 Nov; 13(6):1014-20. PubMed ID: 6075437
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
    Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
    J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator in saliva of the vampire bat Desmodus rotundus.
    Hawkey C
    Nature; 1966 Jul; 211(5047):434-5. PubMed ID: 5967844
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model.
    Montoney M; Gardell SJ; Marder VJ
    Circulation; 1995 Mar; 91(5):1540-4. PubMed ID: 7867196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vampire bat salivary plasminogen activator.
    Gardell SJ; Friedman PA
    Methods Enzymol; 1993; 223():233-49. PubMed ID: 8271956
    [No Abstract]   [Full Text] [Related]  

  • 7. Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding.
    Weitz JI
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):19S-23S. PubMed ID: 8770837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
    Harpel PC; Mosesson MW
    J Clin Invest; 1973 Sep; 52(9):2175-84. PubMed ID: 4269529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
    Kruithof EK; Schleuning WD
    Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator.
    Deguchi K; Murashima S; Shirakawa S; Soria C; Soria J; Dunn F; Tobelem G
    Thromb Res; 1985 Dec; 40(6):853-61. PubMed ID: 3937289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator.
    Gardell SJ; Hare TR; Bergum PW; Cuca GC; O'Neill-Palladino L; Zavodny SM
    Blood; 1990 Dec; 76(12):2560-4. PubMed ID: 2124935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a novel chimeric tissue plasminogen activator with favorable Vampire bat plasminogen activator properties.
    Kazemali M; Majidzadeh-A K; Sardari S; Saadatirad AH; Khalaj V; Zarei N; Barkhordari F; Adeli A; Mahboudi F
    Enzyme Microb Technol; 2014 Dec; 67():82-6. PubMed ID: 25442953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations concerning the substrate specificity of Arvin.
    Exner T; Koppel JL
    Biochim Biophys Acta; 1972 Mar; 258(3):825-9. PubMed ID: 5017705
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of the blood fibrinolytic mechanism in birds by saliva of the vampire bat (Diaemus youngi).
    Cartwright T; Hawkey C
    J Physiol; 1969 Mar; 201(1):45P-46P. PubMed ID: 5773575
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity.
    Schleuning WD; Alagon A; Boidol W; Bringmann P; Petri T; Krätzschmar J; Haendler B; Langer G; Baldus B; Witt W
    Ann N Y Acad Sci; 1992 Dec; 667():395-403. PubMed ID: 1309059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR; Gardell SJ
    Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.